<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04887610</url>
  </required_header>
  <id_info>
    <org_study_id>20-11-008</org_study_id>
    <nct_id>NCT04887610</nct_id>
  </id_info>
  <brief_title>Factors That Influence Blood Vessel Regulation During Exercise in Humans</brief_title>
  <official_title>Factors That Influence Blood Vessel Regulation During Exercise in Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Guelph</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Guelph</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will examine the effects of ischemic preconditioning or a high fat meal on the&#xD;
      capacity of the brachial artery to overcome sympathetic activation and dilate during exercise&#xD;
      (also known as functional sympatholysis). Participants will be asked to complete rhythmic&#xD;
      handgrip exercise with and without the application of -20 mmHg lower body negative pressure&#xD;
      to increase sympathetic activation. Doppler ultrasound will be used to continuously measure&#xD;
      brachial artery blood flow. Near infrared spectroscopy will assess forearm oxygenation and&#xD;
      deoxygenation. Participants will complete the handgrip exercise and lower body negative&#xD;
      pressure before and after the applications of two interventions. Intervention one is active&#xD;
      or control ischemic preconditioning. Intervention two is high or low fat meals.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 20, 2021</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Forearm blood flow</measure>
    <time_frame>Baseline - Immediately before active and control interventions</time_frame>
    <description>Doppler ultrasound</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Forearm blood flow</measure>
    <time_frame>30 minutes after active and control interventions</time_frame>
    <description>Doppler ultrasound</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Forearm vascular conductance</measure>
    <time_frame>Baseline - Immediately before active and control interventions</time_frame>
    <description>Blood flow divided by blood pressure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Forearm vascular conductance</measure>
    <time_frame>30 minutes after active and control interventions</time_frame>
    <description>Blood flow divided by blood pressure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oxygenated hemoglobin</measure>
    <time_frame>Baseline - Immediately before active and control interventions</time_frame>
    <description>Near infrared spectroscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygenated hemoglobin</measure>
    <time_frame>30 minutes after active and control interventions</time_frame>
    <description>Near infrared spectroscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Deoxygenated hemoglobin</measure>
    <time_frame>Baseline - Immediately before active and control interventions</time_frame>
    <description>Near infrared spectroscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Deoxygenated hemoglobin</measure>
    <time_frame>30 minutes after active and control interventions</time_frame>
    <description>Near infrared spectroscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tissue saturation index</measure>
    <time_frame>Baseline - Immediately before active and control interventions</time_frame>
    <description>Near infrared spectroscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tissue saturation index</measure>
    <time_frame>30 minutes after active and control interventions</time_frame>
    <description>Near infrared spectroscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>Baseline - Immediately before active and control interventions</time_frame>
    <description>Finger plethysmography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>30 minutes after active and control interventions</time_frame>
    <description>Finger plethysmography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>Baseline - Immediately before active and control interventions</time_frame>
    <description>ECG</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>30 minutes after active and control interventions</time_frame>
    <description>ECG</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Ischemic Preconditioning</condition>
  <condition>Dietary Exposure</condition>
  <arm_group>
    <arm_group_label>Ischemic preconditioning control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Ischemic preconditioning</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>High fat meal</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Low fat meal</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ischemic preconditioning</intervention_name>
    <description>Four 5-minute cycles of 200 mmHg cuff inflation of the brachial artery, each separated by 5-minutes deflated recovery (i.e. 40 minutes total time)</description>
    <arm_group_label>Ischemic preconditioning</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ischemic preconditioning control</intervention_name>
    <description>Four 5-minute cycles of 20 mmHg cuff inflation of the brachial artery, each separated by 5-minutes deflated recovery (i.e. 40 minutes total time)</description>
    <arm_group_label>Ischemic preconditioning control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High fat meal</intervention_name>
    <description>Meal containing 1000 calories, 6 g fat, 1.5 g saturated fat, 0 g trans fat, 0 mg cholesterol, 187 g carbohydrates, 47 g protein, 450 mg sodium</description>
    <arm_group_label>High fat meal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Low fat meal</intervention_name>
    <description>Meal containing 1030 calories, 60 g fat, 23 g saturated fat, 0.5 g trans fat, 450 mg cholesterol, 79 g carbohydrates, 41 g protein, 2,050 mg sodium.</description>
    <arm_group_label>Low fat meal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years or older&#xD;
&#xD;
          -  Healthy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of smoking (tobacco or cannabis), defined as any smoking within the past 3&#xD;
             months&#xD;
&#xD;
          -  Diagnosed cardiovascular or metabolic disease(s)&#xD;
&#xD;
          -  Recent musculoskeletal injury handgrip exercise&#xD;
&#xD;
          -  Prescription of chronic medications other than oral contraceptives&#xD;
&#xD;
          -  History of hypertension or presence of arrhythmia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Guelph - Human Cardiovascular Physiology Laboratory</name>
      <address>
        <city>Guelph</city>
        <state>Ontario</state>
        <zip>N1G 2W1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philip Millar, PhD</last_name>
      <phone>1-519-824-4120</phone>
      <phone_ext>54818</phone_ext>
      <email>pmillar@uoguelph.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>April 1, 2021</study_first_submitted>
  <study_first_submitted_qc>May 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 14, 2021</study_first_posted>
  <last_update_submitted>September 27, 2021</last_update_submitted>
  <last_update_submitted_qc>September 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Guelph</investigator_affiliation>
    <investigator_full_name>Philip Millar</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

